Jointown Pharmaceutical Group maintained a moderate ROCE of ...

Moomoo AI Dec 7, 2023 16:53

Jointown Pharmaceutical Group maintained a moderate ROCE of 12% but didn't provide high returns to shareholders over five years. Its high liabilities to total assets ratio points to a significant dependency on short-term creditors.

Returns At Jointown Pharmaceutical Group (SHSE:600998) Appear To Be Weighed Down

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

2001 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

4134Followers

0Following

9160Visitors